NDC 17856-0182-2 - ACETAMINOPHEN
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 17856-0182
- Requested NDC
- 17856-0182-2
- Package NDCs from labels
- 17856-0182-2, 17856-0182-1, 17856-0182-3, 17856-0182-5, 17856-0182-4
- Manufacturer
- ATLANTIC BIOLOGICALS CORP. | UNIT DOSE SOLUTIONS
- Effective date
- 2022-11-14
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| ACETAMINOPHEN - ATLANTIC BIOLOGICALS CORP. | UNIT DOSE SOLUTIONS | ATLANTIC BIOLOGICALS CORP. | UNIT DOSE SOLUTIONS | 2022-11-14 | HUMAN OTC DRUG LABEL |
FDA-Initiated Inactive NDC Indexing#
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 17856-0182-3 | 2024-01-30 | C162847 | 48780-1 | 1030e364-fb3f-111a-e063-dadaa90a10e2 | Acetaminophen Elxir Bubble Gum Flavor |
| 17856-0182-4 | 2024-01-30 | C162847 | 48780-1 | 1030e364-fb3f-111a-e063-dadaa90a10e2 | Acetaminophen Elxir Bubble Gum Flavor |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 17856-0182-1 | ACETAMINOPHEN | 120 in 1 BOX, UNIT-DOSE | ELIXIR | 120 | 3 | |
| 17856-0182-2 | ACETAMINOPHEN | 2 mL in 1 SYRINGE | ELIXIR | 2 | 3 | |
| 17856-0182-3 | ACETAMINOPHEN | 5 in 1 SYRINGE | ELIXIR | 5 | 3 | |
| 17856-0182-4 | ACETAMINOPHEN | 72 in 1 BOX, UNIT-DOSE | ELIXIR | 72 | 3 | |
| 17856-0182-5 | ACETAMINOPHEN | 5 mL in 1 CUP, UNIT-DOSE | ELIXIR | 5 | 3 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 17856-0182 | ACETAMINOPHEN ELIXIR [ATLANTIC BIOLOGICALS CORP.] | 3 | Legacy NDC, 5 package rows | 20221115_cf2dd95d-afea-462d-9dba-a46a68bf67e6.zip |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 17856-0182-4 | ML - Milliliter | 17856-0182 | 095990e2-50ba-4bb4-a465-af7821d7ccb3 | 1 | 2023-06-06 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Cold and Flu Nighttime | ACETAMINOPHEN, DEXTROMETHORPHAN HYDROBROMIDE, DOXYLAMINE SUCCINATE | QUALITY CHOICE (Chain Drug Marketing Association) | ca6d43cf-0d1f-4d3c-be7e-e3ac6a24f4fe | 2025-12-16 | Warnings | 362O9ITL9D |
| Cold and Flu Nighttime | ACETAMINOPHEN, DEXTROMETHORPHAN HYDROBROMIDE, DOXYLAMINE SUCCINATE | QUALITY CHOICE (Chain Drug Marketing Association) | e70d0784-53bc-4910-aade-3c9ad6e36441 | 2025-12-16 | Warnings | 362O9ITL9D |
| MAXIMUM STRENGTH NON-ASPIRIN 100 | ACETAMINOPHEN | JHK Inc dba American Safety & First Aid | 1d3e9948-883e-4668-9bb8-d699a283b51a | 2025-12-16 | Warnings | 362O9ITL9D |
| Pain and Sinus | ACETAMINOPHEN AND PHENYLEPHRINE | JHK Inc dba American Safety & First Aid | 88f86f5a-cc2b-4c75-b7a4-f2021922280b | 2025-12-16 | Warnings | 362O9ITL9D |
| Daytime Cold and Flu Non Drowsy | ACETAMINOPHEN, DEXTROMETHORPHAN HYDROBROMIDE, PHENYLEPHRINE HYDROCHLORIDE | QUALITY CHOICE (Chain Drug Marketing Association) | df866cf6-0526-4e61-ac9b-245b57dd5df6 | 2025-12-16 | Warnings | 362O9ITL9D |
| Severe Cold and Flu Relief Daytime | ACETAMINOPHEN, DEXTROMETHORPHAN HYDROBROMIDE, GUAIFENESIN, PHENYLEPHRINE HYDROCHLORIDE | Walgreens | c89200b6-4adb-452e-b931-07f631dad641 | 2025-12-16 | Warnings | 362O9ITL9D |
| ONESSIP ADULT DAYTIME SEVERE COLD AND FLU | ACETAMINOPHEN, DEXTROMETHORPHAN HBR, GUAIFENESIN, PHENYLEPHRINE HCI | MEDWISE LIFESCIENCES INC. | 45fa9159-d74c-063a-e063-6294a90a3ed0 | 2025-12-15 | Warnings | 362O9ITL9D |
| TYLENOL EXTRA STRENGTH, TRAVEL BASIX | ACETAMINOPHEN | Lil' Drug Store Products, Inc. | fa951d50-b79c-4161-8c81-fcf386b0964e | 2025-12-15 | Warnings | 362O9ITL9D |
| Artificial Tears | GLYCERIN | NuCare Pharmaceuticals,Inc. | 97a3d8e2-b2c0-3f5d-e053-2a95a90ac49d | 2025-12-15 | Warnings | B697894SGQ PDC6A3C0OX |
| Vanquish Extra Strength | ACETAMINOPHEN, ASPIRIN, AND CAFFEINE | DSE Healthcare Solutions, LLC | cbf12223-ef44-494b-9d3c-971dce3c5ade | 2025-12-15 | Warnings | 362O9ITL9D |
| equate dual pain reliever | ACETAMINOPHEN, IBUPROFEN | WALMART INC. | 09dc976b-6065-4aad-9d57-0fe5e88a722a | 2025-12-15 | Warnings | 362O9ITL9D |
| Pain Reliever | ACETAMINOPHEN | WALGREENS | 40a1b354-9b2e-1cf3-e063-6394a90af113 | 2025-12-13 | Warnings | 362O9ITL9D |
| ElixirLidoFast Rapid Relief | GLYCERIN, LIDOCAINE, PETROLATUM, AND PHENYLEPHRINE HYDROCHLORIDE | ELIXIR HEALTHCARE USA, LLC. | 45de9dfa-6c89-1eae-e063-6294a90a4dac | 2025-12-13 | Warnings | PDC6A3C0OX |
| topcare childrens pain and fever | ACETAMINOPHEN | Topco Associates LLC | 911492d5-e065-4b8f-b2dc-cb6a6678d0ae | 2025-12-13 | Warnings | 362O9ITL9D |
| Cold and Flu maximum strength | ACETAMINOPHEN, DEXTROMETHORPHAN HBR, GUAIFENESIN, PHENYLEPHRINE HCL | Rite Aid Corporation | ac01206f-a717-4c0b-8a03-fab0a4fd154b | 2025-12-12 | Warnings | 362O9ITL9D |
| Acetaminophen 250 mg and Ibuprofen 125 mg | ACETAMINOPHEN 250 MG AND IBUPROFEN 125 MG TABLETS | MARKSANS PHARMA LIMITED | 46121a30-1361-4f2b-9f3f-3cedabd66c33 | 2025-12-12 | Warnings | 362O9ITL9D |
| Sinus Severe | ACETAMINOPHEN, GUAIFENESIN, PHENYLEPHRINE HCL | Strategic Sourcing Services LLC | dcb80dd5-465d-4792-947a-3044e25a5284 | 2025-12-12 | Warnings | 362O9ITL9D |
| Pain Reliever, Extra Strength, 24-7 Life by 7-Eleven | ACETAMINOPHEN TABLET | Lil' Drug Store Products, Inc. | 45c397bd-a1ff-1246-e063-6394a90ac54a | 2025-12-12 | Warnings | 362O9ITL9D |
| Acetaminophen and Ibuprofen | ACETAMINOPHEN AND IBUPROFEN | DISCOUNT DRUG MART, INC. | f9dfeb0e-0d4d-7348-e053-6394a90a8aef | 2025-12-12 | Warnings | 362O9ITL9D |
| Acetaminophen and Ibuprofen | ACETAMINOPHEN AND IBUPROFEN | Bionpharma Inc. | 04ccc4b2-0cfd-3012-e063-6394a90afa79 | 2025-12-12 | Warnings | 362O9ITL9D |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.